GB1589224A - Cosmetic compositions for the treatment of dry skin - Google Patents
Cosmetic compositions for the treatment of dry skin Download PDFInfo
- Publication number
- GB1589224A GB1589224A GB37156/77A GB3715677A GB1589224A GB 1589224 A GB1589224 A GB 1589224A GB 37156/77 A GB37156/77 A GB 37156/77A GB 3715677 A GB3715677 A GB 3715677A GB 1589224 A GB1589224 A GB 1589224A
- Authority
- GB
- United Kingdom
- Prior art keywords
- parts
- acid
- skin
- volume
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title claims description 48
- 206010013786 Dry skin Diseases 0.000 title claims description 35
- 230000037336 dry skin Effects 0.000 title claims description 35
- 238000011282 treatment Methods 0.000 title claims description 17
- 239000002537 cosmetic Substances 0.000 title claims description 14
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 22
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 20
- 239000007795 chemical reaction product Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 230000000699 topical effect Effects 0.000 claims description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 239000002674 ointment Substances 0.000 claims description 15
- 150000001412 amines Chemical class 0.000 claims description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 10
- 239000004264 Petrolatum Substances 0.000 claims description 9
- 235000019271 petrolatum Nutrition 0.000 claims description 9
- 229940066842 petrolatum Drugs 0.000 claims description 9
- 238000013019 agitation Methods 0.000 claims description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 8
- 239000006210 lotion Substances 0.000 claims description 8
- 239000002480 mineral oil Substances 0.000 claims description 8
- 235000010446 mineral oil Nutrition 0.000 claims description 8
- 239000004094 surface-active agent Substances 0.000 claims description 8
- 238000005336 cracking Methods 0.000 claims description 7
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 6
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 6
- 241000282412 Homo Species 0.000 claims description 6
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 claims description 6
- 206010021198 ichthyosis Diseases 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 6
- 239000003981 vehicle Substances 0.000 claims description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 239000012177 spermaceti Substances 0.000 claims description 5
- 229940084106 spermaceti Drugs 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- 208000024891 symptom Diseases 0.000 claims description 5
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 239000000908 ammonium hydroxide Substances 0.000 claims description 4
- 229960000541 cetyl alcohol Drugs 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 239000005457 ice water Substances 0.000 claims description 4
- 230000003902 lesion Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000000376 reactant Substances 0.000 claims description 4
- 231100000444 skin lesion Toxicity 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 claims description 3
- VOXXWSYKYCBWHO-UHFFFAOYSA-N 3-phenyllactic acid Chemical compound OC(=O)C(O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-UHFFFAOYSA-N 0.000 claims description 3
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims description 3
- UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 claims description 3
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 claims description 3
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 claims description 3
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 235000012343 cottonseed oil Nutrition 0.000 claims description 3
- 239000002385 cottonseed oil Substances 0.000 claims description 3
- 125000005265 dialkylamine group Chemical group 0.000 claims description 3
- 150000004985 diamines Chemical class 0.000 claims description 3
- 229940117360 ethyl pyruvate Drugs 0.000 claims description 3
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 claims description 3
- 235000012209 glucono delta-lactone Nutrition 0.000 claims description 3
- 229960003681 gluconolactone Drugs 0.000 claims description 3
- 229950002441 glucurolactone Drugs 0.000 claims description 3
- 229940097043 glucuronic acid Drugs 0.000 claims description 3
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 229960002510 mandelic acid Drugs 0.000 claims description 3
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 claims description 3
- 229940042472 mineral oil Drugs 0.000 claims description 3
- 229940107700 pyruvic acid Drugs 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- 125000005270 trialkylamine group Chemical group 0.000 claims description 3
- AFENDNXGAFYKQO-VKHMYHEASA-N (S)-2-hydroxybutyric acid Chemical compound CC[C@H](O)C(O)=O AFENDNXGAFYKQO-VKHMYHEASA-N 0.000 claims description 2
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 claims description 2
- MIJDSYMOBYNHOT-UHFFFAOYSA-N 2-(ethylamino)ethanol Chemical compound CCNCCO MIJDSYMOBYNHOT-UHFFFAOYSA-N 0.000 claims description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 2
- 150000003973 alkyl amines Chemical group 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 2
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 claims description 2
- 229940043276 diisopropanolamine Drugs 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 150000002169 ethanolamines Chemical class 0.000 claims description 2
- 238000011221 initial treatment Methods 0.000 claims description 2
- 229940074928 isopropyl myristate Drugs 0.000 claims description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 2
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 claims description 2
- 230000036620 skin dryness Effects 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 239000010409 thin film Substances 0.000 claims description 2
- RKBCYCFRFCNLTO-UHFFFAOYSA-N triisopropylamine Chemical compound CC(C)N(C(C)C)C(C)C RKBCYCFRFCNLTO-UHFFFAOYSA-N 0.000 claims description 2
- -1 Nmethylethanolamine Chemical compound 0.000 claims 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 claims 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 claims 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 229940035049 sorbitan monooleate Drugs 0.000 claims 1
- 239000001593 sorbitan monooleate Substances 0.000 claims 1
- 235000011069 sorbitan monooleate Nutrition 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000028782 Hereditary disease Diseases 0.000 description 2
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/720,835 US4105783A (en) | 1975-07-23 | 1976-09-07 | Therapeutic treatment of dry skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1589224A true GB1589224A (en) | 1981-05-07 |
Family
ID=24895449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB37156/77A Expired GB1589224A (en) | 1976-09-07 | 1977-09-06 | Cosmetic compositions for the treatment of dry skin |
Country Status (15)
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU674142B2 (en) * | 1992-07-24 | 1996-12-12 | Unilever Plc | Use of cosmetic composition |
| EP0822812A4 (en) * | 1995-04-27 | 2000-06-14 | Nicholas V Perricone | LOCAL TREATMENT AND / OR PREVENTION OF SUBCUTANEOUS SOCUS AND OVERLAYING SKIN TISSUE USING ACETYLCHOLINE PRE-STAGES AND CATECHOLAMINES |
| EP0876812A3 (de) * | 1997-05-06 | 2000-07-26 | Basf Aktiengesellschaft | Zuckersäureureide enthaltende kosmetische Zubereitungen |
| FR2821554A1 (fr) * | 2001-03-05 | 2002-09-06 | Johnson & Johnson Consumer Fr | Compositions topiques contenant au moins un derive d'ethanolamine pour le traitement ou la prevention des dommages de la peau associes au vieillissement de la peau et procedes comestique associes |
| EP1219288A3 (en) * | 2000-12-21 | 2003-07-30 | Johnson & Johnson Consumer Companies, Inc. | Treatment for skin |
| US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
| US10266486B2 (en) | 2016-01-29 | 2019-04-23 | Akzo Nobel Chemicals International B.V. | Method of making a composition of an alkanolamine alkylamide and a polyol |
| WO2020128071A1 (en) * | 2018-12-21 | 2020-06-25 | L'oreal | Cosmetic use of a short chain fatty acid (scfa) for preventing and/or treating dry skin and/or aged skin |
| US11154476B2 (en) | 2016-01-29 | 2021-10-26 | Nouryon Chemicals International B.V. | Synergistic effects of alkanolamine alkylamides and other moisturizing agents |
| US11154477B2 (en) | 2016-01-29 | 2021-10-26 | Nouryon Chemicals International B.V. | Use of alkanolamine alkylamides as humectants |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3239317A1 (de) * | 1982-10-23 | 1984-04-26 | Karlheinz Dipl.-Ing. 3450 Holzminden Schrader | Mittel zur pflege oder behandlung der menschlichen haut |
| AU618517B2 (en) * | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
| DE3804141C1 (enrdf_load_stackoverflow) * | 1988-02-11 | 1989-07-06 | Hans Gerd 5650 Solingen De Kaiser | |
| JPH03110754U (enrdf_load_stackoverflow) * | 1990-02-28 | 1991-11-13 | ||
| US5139784A (en) * | 1990-03-13 | 1992-08-18 | Revlon, Inc. | Alkyl diamides and cosmetic treating compositions therewith |
| US5254343A (en) * | 1991-03-19 | 1993-10-19 | Bristol-Myers Squibb Company | Reduction of cutaneous atrophy |
| FR2720938B1 (fr) * | 1994-06-08 | 1996-08-30 | Fabre Pierre Cosmetique | Composition dermato-cosmétologique et son utilisation. |
| IT1288257B1 (it) * | 1996-11-29 | 1998-09-11 | Paoli Ambrosi Gianfranco De | Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico |
| JP5117732B2 (ja) * | 2007-01-29 | 2013-01-16 | 株式会社 メドレックス | 外用剤用の低刺激性溶解助剤 |
| JP5717401B2 (ja) * | 2010-11-04 | 2015-05-13 | 花王株式会社 | スカルプケア剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3549544A (en) * | 1966-10-03 | 1970-12-22 | Swift & Co | Liquid synthetic detergent |
| US3920840A (en) * | 1973-06-19 | 1975-11-18 | Scott Eugene J Van | Treatment of psoriasis with n-methyldiethanolamine |
| US3879537A (en) * | 1973-09-04 | 1975-04-22 | Scott Eugene J Van | Treatment of ichthyosiform dermatoses |
-
1977
- 1977-09-05 BE BE180674A patent/BE858404A/xx not_active IP Right Cessation
- 1977-09-05 PH PH20200A patent/PH13782A/en unknown
- 1977-09-06 CY CY1245A patent/CY1245A/xx unknown
- 1977-09-06 GB GB37156/77A patent/GB1589224A/en not_active Expired
- 1977-09-06 AU AU28583/77A patent/AU519802B2/en not_active Expired
- 1977-09-06 ZA ZA00775363A patent/ZA775363B/xx unknown
- 1977-09-06 FR FR7727003A patent/FR2363326A1/fr active Granted
- 1977-09-07 JP JP10687777A patent/JPS5396329A/ja active Granted
- 1977-09-07 DE DE19772740349 patent/DE2740349A1/de active Granted
- 1977-09-07 CA CA286,278A patent/CA1115211A/en not_active Expired
- 1977-09-07 PT PT67007A patent/PT67007B/pt unknown
-
1979
- 1979-04-12 FR FR7909328A patent/FR2422398A1/fr active Granted
-
1984
- 1984-04-02 SG SG275/84A patent/SG27584G/en unknown
- 1984-04-12 KE KE3401A patent/KE3401A/xx unknown
-
1985
- 1985-06-13 HK HK462/85A patent/HK46285A/en not_active IP Right Cessation
- 1985-12-30 MY MY566/85A patent/MY8500566A/xx unknown
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU674142B2 (en) * | 1992-07-24 | 1996-12-12 | Unilever Plc | Use of cosmetic composition |
| EP0822812A4 (en) * | 1995-04-27 | 2000-06-14 | Nicholas V Perricone | LOCAL TREATMENT AND / OR PREVENTION OF SUBCUTANEOUS SOCUS AND OVERLAYING SKIN TISSUE USING ACETYLCHOLINE PRE-STAGES AND CATECHOLAMINES |
| EP0876812A3 (de) * | 1997-05-06 | 2000-07-26 | Basf Aktiengesellschaft | Zuckersäureureide enthaltende kosmetische Zubereitungen |
| US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
| EP1219288A3 (en) * | 2000-12-21 | 2003-07-30 | Johnson & Johnson Consumer Companies, Inc. | Treatment for skin |
| FR2821554A1 (fr) * | 2001-03-05 | 2002-09-06 | Johnson & Johnson Consumer Fr | Compositions topiques contenant au moins un derive d'ethanolamine pour le traitement ou la prevention des dommages de la peau associes au vieillissement de la peau et procedes comestique associes |
| US10266486B2 (en) | 2016-01-29 | 2019-04-23 | Akzo Nobel Chemicals International B.V. | Method of making a composition of an alkanolamine alkylamide and a polyol |
| US11154476B2 (en) | 2016-01-29 | 2021-10-26 | Nouryon Chemicals International B.V. | Synergistic effects of alkanolamine alkylamides and other moisturizing agents |
| US11154477B2 (en) | 2016-01-29 | 2021-10-26 | Nouryon Chemicals International B.V. | Use of alkanolamine alkylamides as humectants |
| WO2020128071A1 (en) * | 2018-12-21 | 2020-06-25 | L'oreal | Cosmetic use of a short chain fatty acid (scfa) for preventing and/or treating dry skin and/or aged skin |
Also Published As
| Publication number | Publication date |
|---|---|
| KE3401A (en) | 1984-06-08 |
| MY8500566A (en) | 1985-12-31 |
| FR2363326B1 (enrdf_load_stackoverflow) | 1980-09-19 |
| PT67007A (en) | 1977-10-01 |
| PH13782A (en) | 1980-09-26 |
| SG27584G (en) | 1985-01-04 |
| FR2422398B1 (enrdf_load_stackoverflow) | 1982-11-12 |
| FR2363326A1 (fr) | 1978-03-31 |
| ZA775363B (en) | 1978-07-26 |
| JPH0231053B2 (enrdf_load_stackoverflow) | 1990-07-11 |
| FR2422398A1 (fr) | 1979-11-09 |
| PT67007B (en) | 1979-09-12 |
| DE2740349C2 (enrdf_load_stackoverflow) | 1989-04-06 |
| CY1245A (en) | 1984-06-29 |
| AU2858377A (en) | 1979-03-15 |
| BE858404A (fr) | 1978-03-06 |
| AU519802B2 (en) | 1981-12-24 |
| DE2740349A1 (de) | 1978-03-09 |
| JPS5396329A (en) | 1978-08-23 |
| CA1115211A (en) | 1981-12-29 |
| HK46285A (en) | 1985-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4105783A (en) | Therapeutic treatment of dry skin | |
| US4197316A (en) | Treatment of dry skin | |
| US4105782A (en) | Treatment of acne and dandruff | |
| GB1589224A (en) | Cosmetic compositions for the treatment of dry skin | |
| US4234599A (en) | Treatment of skin keratoses with α-hydroxy acids and related compounds | |
| US4283386A (en) | Method for hair care | |
| US4224339A (en) | Treatment of disturbed keratinization | |
| US3988470A (en) | Treatment of palmar and plant disturbed keratosis | |
| US3984566A (en) | Method of alleviating the symptoms of dandruff | |
| US3920835A (en) | Treatment of disturbed keratinization | |
| US4246261A (en) | Additives enhancing topical corticosteroid action | |
| US4610978A (en) | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same | |
| US6558710B1 (en) | Topical zinc compositions and methods of use | |
| CA1279576C (en) | Treatment of skin disorders | |
| CA2301009C (en) | Skin care compositions and use | |
| JPH09508386A (ja) | 水性局所組成物 | |
| EP1435927B1 (en) | Use of totarol for the treatment of pruritus | |
| US6403654B1 (en) | Compositions for and method of treatment for psoriasis | |
| US5258391A (en) | Phenyl alpha acyloxyalkanoic acids, derivatives and their therapeutic use | |
| US5674539A (en) | Method of treating skin and composition | |
| UA73491C2 (uk) | Застосування солей 1-алкілнікотинової кислоти та її похідних для лікування шкірних захворювань та пошкоджень (варіанти), спосіб лікування та фармацевтична або косметологічна композиція | |
| US3932653A (en) | Composition and method for topical administration of griseofulvin | |
| US3663716A (en) | Method of treating acne with benzyl alcohol | |
| US4035510A (en) | Treatment of acne utilizing N-methyldiethanolamine | |
| JPS6155893B2 (enrdf_load_stackoverflow) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| 429A | Application made for amendment of specification (sect. 29/1949) | ||
| 429H | Application (made) for amendment of specification now open to opposition (sect. 29/1949) | ||
| 429D | Case decided by the comptroller ** specification amended (sect. 29/1949) | ||
| SP | Amendment (slips) printed | ||
| PE20 | Patent expired after termination of 20 years |
Effective date: 19970905 |